• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OCC 1.35% 37.5¢

ORTHOCELL LIMITED

Orthocell Limited is an Australia-based regenerative medicine company. The Company is... Orthocell Limited is an Australia-based regenerative medicine company. The Company is focused on regenerating mobility for patients by developing products for the repair of a variety of bone and soft tissue injuries. Its portfolio of products includes CelGro, Striate+, Remplir, and SmrtGraft. CelGro is a collagen medical device that facilitates tissue reconstruction and healing in a variety of dental and orthopedic reconstructive applications. CelGro is manufactured using a SMRT manufacturing process to preserve the natural collagen structure. Striate+ is used for dental GBR applications. Remplir is for peripheral nerve reconstruction. SmrtGraft is for tendon repair. Its other major products are autologous cell therapy, which focuses on regenerating damaged tendon and cartilage tissue. It is engaged in the development of its tendon cell therapy in the United States. Its autologous tendon therapy is an advanced injectable cellular therapy for the treatment of chronic tendon injuries.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OCC
Media thread
7 8 9
10/05/24 512 158K
10/05/24 Last post  fishermancray Comments Created with Sketch.  512  Views Created with Sketch.  158K 
OCC
OCC Trading
26 27 28
09/05/24 1.6K 472K
09/05/24 Last post  rae915 Comments Created with Sketch.  1.6K  Views Created with Sketch.  472K 
OCC 07/05/24 5 1.3K
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

AUQ
10 May 2024
ALARA RESOURCES LIMITED
07/05/24 Last post  MikesLM Comments Created with Sketch.  5  Views Created with Sketch.  1.3K 
OCC 02/05/24 13 3.7K
02/05/24 Last post  flummoxedtrader Comments Created with Sketch.  13  Views Created with Sketch.  3.7K 
OCC
Stem Cell Therapy advancements
6 7 8
27/04/24 456 148K
27/04/24 Last post  flummoxedtrader Comments Created with Sketch.  456  Views Created with Sketch.  148K 
OCC 25/04/24 15 4.8K
25/04/24 Last post  scolloymore Comments Created with Sketch.  15  Views Created with Sketch.  4.8K 
OCC 24/04/24 4 910
24/04/24 Last post  rae915 Comments Created with Sketch.  4  Views Created with Sketch.  910 
OCC 17/04/24 8 2.1K
17/04/24 Last post  flummoxedtrader Comments Created with Sketch.  8  Views Created with Sketch.  2.1K 

See All Discussions arrow Created with Sketch.

Timeline

Compelling 85% Success Rate Remplir Study now published
30 Apr 09:49
 
Change of Director's Interest Notice-John Van Der Wielen
24 Apr 11:52
 
Securities Trading Policy
24 Apr 11:23
 
Change of Director's Interest Notice-John Van Der Wielen
16 Apr 08:56
 
Orthocell receives $3.05m R&D tax incentive refund
15 Apr 09:03
 
Quarterly Activity Report & Appendix 4C
08 Apr 09:03
 
View More arrow Created with Sketch.
(20min delay)
Last
37.5¢
Change
0.005(1.35%)
Mkt cap ! $78.49M
Open High Low Value Volume
36.5¢ 37.5¢ 36.5¢ $32.14K 86.68K

Buyers (Bids)

No. Vol. Price($)
1 65604 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 5000 1
View Market Depth
Last trade - 12.55pm 10/05/2024 (20 minute delay) ?
Last
37.5¢
  Change
0.005 ( 1.35 %)
Open High Low Volume
37.0¢ 38.0¢ 37.0¢ 21015
Last updated 12.55pm 10/05/2024 ?
OCC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.